MedPath

Imlygic

These highlights do not include all the information needed to use IMLYGIC safely and effectively. See full prescribing information for IMLYGIC . I MLYGIC ( talimogene laherparepvec ) Suspension for intralesional injection Initial U.S. Approval: 2015

Approved
Approval ID

64ffb680-ea8c-42fc-9649-9e8c0eb77ddb

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Feb 10, 2023

Manufacturers
FDA

Amgen Inc

DUNS: 039976196

Products 2

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

talimogene laherparepvec

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code55513-079
Application NumberBLA125518
Product Classification
M
Marketing Category
C73585
G
Generic Name
talimogene laherparepvec
Product Specifications
Route of AdministrationINTRALESIONAL
Effective DateFebruary 10, 2023
FDA Product Classification

INGREDIENTS (7)

TALIMOGENE LAHERPAREPVECActive
Quantity: 100000000 [PFU] in 1 mL
Code: 07730V90L6
Classification: ACTIB
SODIUM PHOSPHATE, DIBASIC, DIHYDRATEInactive
Quantity: 15.4 mg in 1 mL
Code: 94255I6E2T
Classification: IACT
SODIUM PHOSPHATE, MONOBASIC, DIHYDRATEInactive
Quantity: 2.44 mg in 1 mL
Code: 5QWK665956
Classification: IACT
SODIUM CHLORIDEInactive
Quantity: 8.5 mg in 1 mL
Code: 451W47IQ8X
Classification: IACT
SORBITOLInactive
Quantity: 20 mg in 1 mL
Code: 506T60A25R
Classification: IACT
INOSITOLInactive
Quantity: 40 mg in 1 mL
Code: 4L6452S749
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT

talimogene laherparepvec

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code55513-078
Application NumberBLA125518
Product Classification
M
Marketing Category
C73585
G
Generic Name
talimogene laherparepvec
Product Specifications
Route of AdministrationINTRALESIONAL
Effective DateFebruary 10, 2023
FDA Product Classification

INGREDIENTS (7)

TALIMOGENE LAHERPAREPVECActive
Quantity: 1000000 [PFU] in 1 mL
Code: 07730V90L6
Classification: ACTIB
SODIUM PHOSPHATE, DIBASIC, DIHYDRATEInactive
Quantity: 15.4 mg in 1 mL
Code: 94255I6E2T
Classification: IACT
SODIUM CHLORIDEInactive
Quantity: 8.5 mg in 1 mL
Code: 451W47IQ8X
Classification: IACT
SODIUM PHOSPHATE, MONOBASIC, DIHYDRATEInactive
Quantity: 2.44 mg in 1 mL
Code: 5QWK665956
Classification: IACT
INOSITOLInactive
Quantity: 40 mg in 1 mL
Code: 4L6452S749
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT
SORBITOLInactive
Quantity: 20 mg in 1 mL
Code: 506T60A25R
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Imlygic - FDA Drug Approval Details